Janus Henderson Investors US’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Janus Henderson Investors US's DGX Position: Q1 2017 in Review
Janus Henderson Investors US increased its Quest Diagnostics (DGX) stake by 34% in Q1 2017, buying an estimated $32.6M and bringing the position to 1,339,007 shares worth $131M. The position accounts for 0.11% of the portfolio, ranked #237.
Janus Henderson Investors US first reported a position in DGX in Q2 2013 and has held it in 16 quarters since. 614 funds tracked by Wall St. Rank hold DGX as of Q1 2017.
- Janus Henderson Investors US held 1,339,007 shares of Quest Diagnostics worth $131M as of Q1 2017.
- Janus Henderson Investors US bought 341,476 Quest Diagnostics shares in Q1 2017, an estimated $32.6M.
- Quest Diagnostics made up 0.11% of Janus Henderson Investors US's portfolio in Q1 2017, its #237 holding.
- Janus Henderson Investors US first reported a position in Quest Diagnostics in Q2 2013 and has held it in 16 quarters since.
- 614 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2017.
Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.